Search
for
Sort by
Research 721–750 of 1000+
- Comparison of three different lactic acid bacteria-fermented proteins on RAW 264.7 osteoclast and MC3T3-E1 osteoblast differentiation
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Suppression of uterine and placental ferroptosis by N-acetylcysteine in a rat model of polycystic ovary syndrome
- Androgenetic alopecia and metabolic syndrome: A cross-sectional study in Northeast India
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Association of Acne Tarda with Endocrinological Disorders
- Long-Term Effects of COVID-19
- The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson’s disease
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study
- Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study
- Finasteride, a 5alpha-reductase enzyme inhibitor, alone and synergism with a neurosteroid reduces responsiveness to nociceptive stimuli in male rat
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia (vol 35, pg e243, 2021)
- MP85-05 SEXUAL DYSFUNCTION AFTER 5-ALPHA REDUCTASE INHIBITOR USE: INSIGHTS FROM THE REDUCE STUDY GROUP DATABASE
- Increased scalp skin and serum 5 alpha-reductase reduced androgens in a man relevant to the acquired progressive kinky hair disorder and developing androgenetic alopecia
- Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study
- Reduced levels of 5-α reductase 2 in adult prostate tissue and implications for BPH therapy
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- In vivo evidence for an increase in 5alpha‐reductase activity in the rat central nervous system following morphine exposure
- Anti-nociceptive and anti-inflammatory properties of 5alpha-reductase inhibitor finasteride in experimental animals
- Long-Term Experience With 5-alpha-Reductase Inhibitors.
- Comparison of Finasteride (Proscar®) and Serenoa repens (Permixon®) in the Inhibition of 5-Alpha Reductase in Healthy Male Volunteers
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men.
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Level-1 Data From the REDUCE Study and the PCPT Data
- Abstract A12: Androgen receptor inhibition is involved in Finasteride-reduced AML cell proliferation
- Clinical and hormonal effects of the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism.